Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 199,389 | 160,447 | 114,531 | 44,545 | 91,874 |
| Depreciation Amortization | 11,324 | 8,374 | 4,745 | 2,357 | 9,250 |
| Income taxes - deferred | 31,217 | 25,117 | 19,423 | 2 | -5,677 |
| Accounts receivable | -131 | 469 | 469 | 319 | 581 |
| Accounts payable and accrued liabilities | -2,012 | -2,655 | -2,416 | -2,254 | 2,170 |
| Other Working Capital | -73,181 | -70,204 | -51,549 | -60,106 | 70,649 |
| Other Operating Activity | 3,176 | 3,088 | 2,720 | 1,985 | 15,453 |
| Operating Cash Flow | $169,782 | $124,636 | $87,923 | $-13,152 | $184,300 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -74,744 | -71,697 | -58,359 | -48,313 | -46,668 |
| Sale Of Investment | 50,696 | 39,146 | 26,146 | 17,881 | 9,772 |
| Purchase Sale Intangibles | N/A | N/A | -50 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -50 | 0 | 0 |
| Investing Cash Flow | $-24,048 | $-32,551 | $-32,263 | $-30,432 | $-36,896 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 149,712 | 149,643 | N/A | 82,039 |
| Debt Repayment | -244,751 | -223,466 | -197,034 | -20,311 | -203,977 |
| Common Stock Issued | 149,712 | N/A | N/A | N/A | N/A |
| Dividend Paid | -83,828 | -62,876 | -41,924 | -20,966 | -130,043 |
| Other Financing Activity | -9,897 | -9,897 | -9,897 | 0 | 12,924 |
| Financing Cash Flow | $-188,764 | $-146,527 | $-99,212 | $-41,277 | $-239,057 |
| Beginning Cash Position | 211,574 | 211,574 | 211,574 | 211,574 | 303,227 |
| End Cash Position | 168,544 | 157,132 | 168,022 | 126,713 | 211,574 |
| Net Cash Flow | $-43,030 | $-54,442 | $-43,552 | $-84,861 | $-91,653 |
| Free Cash Flow | |||||
| Operating Cash Flow | 169,782 | 124,636 | 87,923 | -13,152 | 184,300 |
| Free Cash Flow | 169,782 | 124,636 | 87,923 | -13,152 | 184,300 |